Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Source: PAGB
“I’m optimistic about the future of self-care,” said PAGB president Neil Lister on the occasion of the association’s 100-year anniversary. “If we work together, we can support the cultural and behavioral change we need in our country to fully embed self-care in our everyday lives.”
At a gala event at London’s Science Museum to celebrate PAGB’s centenary, Lister told the assembled guests – drawn from manufacturers, regulators, industry groups, agencies and healthcare professionals – that collaboration would be key for the association to emulate the achievements of the past 100 years. “We can’t do this on our own,” he insisted. “We want to build on the partnership working that has been so important to us throughout our history.”
PAGB had “come a long way” since its founding in 1919 as the Association of the Manufacturers of British Proprietaries, Lister pointed out, embracing change and adopting new technologies. But there was “still a lot more to do,” he insisted.
“The industry has a big agenda,” Lister revealed, “including responding to the challenges of EU exit, maximizing the opportunities new digital technologies offer us, and addressing environmental concerns.” (Also see "AESGP Annual Meeting, Day 2: Grappling With Environmental Concerns, 'Nudging' Towards Self-Care Adoption, And Future Trends" - HBW Insight, 6 Jun, 2019.)
PAGB would continue to call for a national strategy for self-care, Lister noted, and to encourage government to implement policies which would “make it easier for people to take responsibility for their own health and well being.” (Also see "PAGB sets out self-care vision" - HBW Insight, 10 Aug, 2018.)
Pharmacy had a key role to play in this, he insisted, alongside other healthcare professionals.
“Most of all though,” Lister concluded, “as a responsible industry we want to continue to work closely with regulators to make sure people have access to effective products that they can use to self-care for themselves and their families.”
Lister thanked guests for supporting PAGB “then, now and for tomorrow.”
HBW Insight: Health, Beauty and Wellness
In latest study casting doubt on the nutrients' effect on chronic illness, researchers find vitamin D and fish oil ineffective in staving off type 2 diabetics' kidney failure. Editorial also published in JAMA says further research is needed to analyze the nutrients’ possible benefits to diabetics with chronic kidney disease.
Topics Clinical trials
HBW Insight: Health, Beauty and Wellness
By David Ridley
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
HBW Insight: Health, Beauty and Wellness
"This was an area that the agency thought was just going to disappear on its own," says Freddie Ann Hoffman, who chaired FDA homeopathic working group that helped develop CPG adopted in 1988 to allow sales of homeopathics to continue without pre-market approval.
Topics FDA Policy and regulation
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, you stay on top of breaking events, what’s in the drugs pipeline, upcoming milestones, clinical trial results and their impact on the markets you care about
From discovery to patent expiry, and coverage spanning both ethical and generic drugs, Medtrack has you covered. Stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool.
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
Looking for more products Product Finder
